Cleared Traditional

PuraStat

K222481 · 3-D Matrix, Inc. · General & Plastic Surgery
Feb 2023
Decision
195d
Days
Class 2
Risk

About This 510(k) Submission

K222481 is an FDA 510(k) clearance for the PuraStat, a Hemostatic Device For Endoscopic Gastrointestinal Use (Class II — Special Controls, product code QAU), submitted by 3-D Matrix, Inc. (Newton, US). The FDA issued a Cleared decision on February 28, 2023, 195 days after receiving the submission on August 17, 2022. This device falls under the General & Plastic Surgery review panel. Regulated under 21 CFR 878.4456.

Submission Details

510(k) Number K222481 FDA.gov
FDA Decision Cleared SESE
Date Received August 17, 2022
Decision Date February 28, 2023
Days to Decision 195 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF

Device Classification

Product Code QAU — Hemostatic Device For Endoscopic Gastrointestinal Use
Device Class Class II — Special Controls
CFR Regulation 21 CFR 878.4456
Definition Hemostatic Device For Intraluminal Gastrointestinal Use. A Hemostatic Device For Intraluminal Gastrointestinal Use Is A Prescription Device That Is Endoscopically Applied To The Upper And/or Lower Gastrointestinal Tract And Is Intended To Produce Hemostasis Via Absorption Of Fluid Or By Other Physical Means.